RethinQ Study - Evaluating Pacing in Heart Failure Patients

Sponsor

Abbott Medical Devices (Industry)

Overall Status

Completed

CT.gov ID

NCT00132977

Collaborator

(none)

250

Enrollment

Locations

Duration (Months)

7.4

Patients Per Site

0.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Patients with heart failure have a pumping action of the ventricles in which one ventricle contracts before the other ventricle. This uncoordinated (unsynchronized) pumping is due to a delay in the stimulation of the left ventricle because of its increased size. Pacing both the right and the left side of the heart (or cardiac resynchronization therapy [CRT]) has been proven to be effective in the treatment of heart failure (HF). Current market-approved devices combine both pacing (CRT) and shocking (implantable cardioverter defibrillator [ICD]) therapy for patients who have severe heart failure and are at risk for developing life-threatening heart rhythms. These devices provide an electrical pacing stimulus to both ventricles and may help the heart contract in a more coordinated way and improve heart failure symptoms.

The investigational portion of this trial involves the implantation of a market-approved CRT implantable cardioverter defibrillator (CRT-D) system in patients who do not meet the current criteria for a CRT implant. In order to receive a CRT-D implant today, patients must have heart failure symptoms, have a weakened heart muscle, and have uncoordinated pumping of the heart. To demonstrate this uncoordinated pumping of the heart, a test (electrocardiogram [ECG]) is done. It is believed that by using a different test (echocardiogram) to measure whether this uncoordinated pumping is present, more patients will be identified that will benefit from CRT-D therapy. This study will look at whether patients identified by using this echocardiogram test show a benefit from having this CRT-D therapy.

Condition or Disease	Intervention/Treatment	Phase
Heart Failure	Device: Cardiac Resynchronization Therapy	Phase 3

Detailed Description

1.0 Problem of Interest

Patients with heart failure have a pumping action of the ventricles in which one ventricle contracts before the other ventricle. This uncoordinated (unsynchronized) pumping is due to a delay in the stimulation of the left ventricle because of its increased size. Pacing both the right and the left side of the heart (or cardiac resynchronization therapy [CRT]) has been proven to be effective in the treatment of heart failure. Current market-approved devices combine both pacing (CRT) and shocking (ICD) therapy for patients who have severe heart failure and are at risk for developing life-threatening heart rhythms. These devices provide an electrical pacing stimulus to both ventricles at the same time and may help the heart contract in a more coordinated way and improve heart failure symptoms.

The investigational portion of this trial involves the implantation of a market-approved CRT implantable cardioverter defibrillator (CRT-D) system in patients who do not meet the current criteria for a CRT implant. In order to receive a CRT-D implant today, patients must have heart failure symptoms, have a weakened heart muscle, and have uncoordinated pumping of the heart. To demonstrate this uncoordinated pumping of the heart, a test (ECG) is done. It is believed that by using a different test (echocardiogram) to measure whether this uncoordinated pumping is present, more patients will be identified that will benefit from CRT-D therapy.

2.0 Study Summary

Testing will be performed to determine if patients are eligible for this study. An EKG (electrical tracing of the heart) will be performed. They will be asked to complete a 6- minute hall walk test that will provide information regarding their ability to exercise and conduct daily activities. An echocardiogram with tissue Doppler imaging (ultrasound of the heart) will be performed to determine how the heart muscle contracts. Results of this echocardiogram will determine if patients are eligible to participate in this study.

The device system that will be implanted consists of a St. Jude Medical CRT-D and three pacing leads (insulted wires that carry electrical energy from the device to the heart). One lead is placed in the upper right chamber of the heart (atrium), a second lead is placed in the lower right chamber of the heart (right ventricle) and the third lead is placed within a vein that runs along the outside of the heart and is positioned at a location near the left lower chamber of the heart (left ventricle).

A randomization visit will occur approximately 14 days after implant. Patients will be randomized (like a flip of a coin) to one of two groups. Each patient will have an equal chance of being randomized to either of the two groups. One group will receive cardiac resynchronization treatment (CRT ON) and the other group will not receive cardiac resynchronization treatment (CRT OFF). Patients in the CRT OFF group can receive cardiac resynchronization treatment at 6 months after randomization if the doctor determines that it is appropriate.

Prior to randomization and programming of the device, the following tests will be completed:

Quality of Life Questionnaire - contains 21 questions that provide information as to how heart failure affects the patient's daily life.
EKG
6-Minute Hall.
Cardiopulmonary Exercise Stress Testing (CPX) - measures the amount of oxygen used by your body while exercising on a treadmill and breathing through a special breathing tube
Echocardiogram

Follow-up visits will occur at 3 and 6 months following randomization and every 6 months thereafter until the end of the study. The tests performed at the randomization visit (Quality of Life Questionnaire, EKG, 6 minute hall walk, CPX and echocardiogram) will be repeated at the 6-month follow-up visit. Additionally, each visit will include a review of the patient's condition and current medications and an evaluation of the CRT-D device.

3.0 How Will the Research Advance Scientific Knowledge and/or Human Health?

It is hoped that by pacing both lower chambers of the heart in these patients that they will feel better. They may be able to do more activities with fewer symptoms. In addition, the information gathered in this study will add to the understanding of treatment options for patients with heart failure.

4.0 What is the Current Standard of Care?

Alternative treatments to the St. Jude Medical CRT-D system (includes the left heart lead) currently available include implantation of a standard ICD system and/or treatment with medications.

Study Design

Study Type:

Interventional

Actual Enrollment :

250 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Double

Primary Purpose:

Treatment

Official Title:

Resynchronization Therapy in Normal QRS (RethinQ) Clinical Investigation

Study Start Date :

Jul 1, 2005

Actual Primary Completion Date :

Jul 1, 2007

Actual Study Completion Date :

Jul 1, 2007

Outcome Measures

Primary Outcome Measures

Cardiac resynchronization therapy (CRT) effectiveness will be evaluated in terms of exercise capacity (peak VO2), as measured by cardiopulmonary exercise testing [6 months]
Safety will be evaluated in terms of survival from CRT-D system-related complications. [6 months]

Secondary Outcome Measures

Quality of Life Questionnaire [6 months]
New York Heart Association (NYHA) Classification [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Have an approved indication for implantation of an ICD.
Have advanced HF with a New York Heart Association (NYHA) Classification of III, despite receiving optimal pharmacological therapy.
Have a stable heart failure medical regimen.
Have a left ventricular ejection fraction (LVEF) <= 35%.
Have evidence of mechanical dyssynchrony as measured by echocardiography using tissue Doppler imaging or M-mode.
Have a QRS duration < 130 ms (present in all ECG leads).
Have the ability to complete exercise stress testing and 6-minute hall walk test, with the only limiting factors being related to cardiac fitness.
Have the ability to independently comprehend and complete a quality of life questionnaire.
Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluations.

Exclusion Criteria:

Have a standard bradycardic indication for pacing.
Have been previously treated with CRT.
Have continuous atrial fibrillation [AF] (continuous is defined as AF lasting > 1 month) within 1 year prior to enrollment or have undergone cardioversion for AF in the past month.
Have the ability to walk > 450 meters during the 6-minute walk test.
Have a NYHA Classification of I, II or IV.
Have symptomatic chronic obstructive pulmonary disease (COPD) as it relates to exercise ability.
Have a classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 6 months.
Have had a recent myocardial infarction, unstable angina or cardiac revascularization (percutaneous transluminal coronary angioplasty [PTCA] or coronary artery bypass graft [CABG]) within 40 days of enrollment.
Have had a recent cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 3 months of enrollment.
Have severe musculoskeletal disorder(s).
Pregnant or planning for pregnancy in the next 6 months.
Currently participating in, or have participated in any clinical investigation within the last 30 days (the only exception being that of a registry trial).
Have a life expectancy of less than 6 months.
Less than 18 years of age.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University Hospital University of Alabama at Birmingham	Birmingham	Alabama	United States	35294
2	Arizona Arrhythmia Consultants	Scottsdale	Arizona	United States	85251
3	Arkansas Cardiology, PA	Little Rock	Arkansas	United States	72205
4	Arkansas Heart Hospital	Little Rock	Arkansas	United States	72211
5	Glendale Memorial Hospital and Medical Center	Glendale	California	United States	91204
6	Scripps Green Hospital	La Jolla	California	United States	92037
7	Mercy General Hospital	Sacramento	California	United States	95819
8	St. Francis Hospital and Medical Center	Hartford	Connecticut	United States	06105
9	Shands Jacksonville	Jacksonville	Florida	United States	32209
10	Orlando Regional Medical Center	Orlando	Florida	United States	32806
11	Emory University	Atlanta	Georgia	United States	30306
12	Unversity of Chicago	Chicago	Illinois	United States	30322
13	Loyola University Medical Center	Maywood	Illinois	United States	60153
14	Iowa Heart Center	Des Moines	Iowa	United States	50314
15	Central Baptist Hospital	Lexington	Kentucky	United States	40503
16	Massachusetts General Hospital	Boston	Massachusetts	United States	02114
17	Baystate Medical Center	Springfield	Massachusetts	United States	01199
18	St. John Hospital and Medical Center	Detroit	Michigan	United States	48236
19	Ingham Regional Medical Center	Lansing	Michigan	United States	48910
20	United Hospital	Saint Paul	Minnesota	United States	55102
21	Nebraska Heart Institute	Lincoln	Nebraska	United States	68526
22	Deborah Heart and Lung Center	Browns Mills	New Jersey	United States	08015
23	New York Presbyterian Hospital/Cornell University	New York	New York	United States	10021
24	Mount Sinai Hospital	New York	New York	United States	10029
25	St. Francis Hospital	Roslyn	New York	United States	11576
26	University Hospitals of Cleveland	Cleveland	Ohio	United States	44106
27	Cleveland Clinic Foundation	Cleveland	Ohio	United States	44195
28	The Ohio State University	Columbus	Ohio	United States	43210
29	Elyria Regional Medical Center	Elyria	Ohio	United States	44035
30	Hospital of the University of Pennsylvania	Philadelphia	Pennsylvania	United States	19104
31	Main Line Health Center/Lankenau Hospital	Wynnewood	Pennsylvania	United States	10969
32	Medical University of Southern California	Charleston	South Carolina	United States	29401
33	Stern Cardiovascular Center	Germantown	Tennessee	United States	38138
34	St. Thomas Hospital	Nashville	Tennessee	United States	37205